Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal function

Journal of Human Hypertension

Volumn 13, Issue 1, 1999, Pages 47-53

  Fogari, Roberto ^a   Zoppi, A ^a   Corradi, L ^a   Mugellini, A ^a   Lazzari, P ^a   Preti, P ^a   Lusardi, P ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Nitrendipine; Ramipril; Type II diabetes

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; NITRENDIPINE; RAMIPRIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN RESTRICTION; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SODIUM RESTRICTION;

EID: 0032896098     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000732     Document Type: Article

References (44)

1. Cooper ME et al. Effects of genetic hypertension on diabetic nephropathy in the rat. Functional and structural characteristics. J Hypertens 1988; 6: 1009-1016.
2. Mogensen CE. Renal function changes in diabetes. Diabetes 1976; 25: 872-879.
3. Parving HH, Andersen AR, Smidt UM, Svendsen PA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983; 1: 1175-1178.
4. Mogensen CE. Long-term antihypertensive treatment inhibits progression of diabetic nephropathy. Br Med J 1982; 285: 685-688.
5. Ravid M et al. Proteinuria, renal impairment, metabolic control and blood pressure in type 2 diabetes mellitus. A 14-year follow-up report on 195 patients. Arch Intern Med 1992; 152: 1225-1229.
6. Kasiske BL et al. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129-138.
7. Marre M et al. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988; 297: 1092-1095.
8. Laffel LMB, McGill JB, Gans JD. The beneficial effect of angiotensin converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. Am J Med 1995; 99: 497-504.
9. The Microalbuminuria Study Group. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. Diabetologia 1996; 39: 587-593.
10. Ravid M et al. Long-term stabilizing effect of angiotensin converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993; 118: 577-581.
11. Ravid M, Lang R, Rachmani R, Lishner M. Long-term nephroprotective effect of angiotensin converting enzyme inhibition in non-insulin dependent diabetes mellitus. Arch Intern Med 1996; 156: 286-289.
12. Sano T et al. Effects of long-term enalapril treatment on persistent microalbuminuria in well-controlled hypertensive and normotensive NIDDM patients. Diabetes Care 1994; 7: 420-424.
13. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD for the Collaborative Study Group. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329; 1456-1462.
14. Maschio G et al. Effect of the angiotensin converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-945.
15. Harris DHC, Hammond WS, Burke TJ, Schrier R. Verapamil protects against progression of experimental renal failure. Kidney Int 1987; 31: 41-46.
16. Nickerson PA. A low dose of a calcium antagonist (nitrendipine) amelioretas cardiac and renal lesions induced by DOC in the rat. Exp Mol Pathol 1984; 41: 309-320.
17. Bakris GL, Barnhill BW, Sadler R. Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection. Kidney Int 1992; 41: 912-919.
18. De Marie BK, Bakris GL. Effects of different classes of calcium antagonists on proteinuria in diabetic subjects. Ann Intern Med 1990; 113: 987-988.
19. Slataper R, Vicknair N, Sadler R, Bakris GL. Comparative effects of different antihypertensive treatments on progression of diabetic renal disease. Arch Intern Med 1993; 153: 973-980.
20. Bakris GL, Copley JB, Vicknair N, Leugans S. Effect of nondihydropyridine calcium antagonists (NDCAs) on progression of nephropathy from non insulin dependent diabetes (NIDDM): a five year follow-up study (Abstract). J Am Soc Nephrol 1995; 6: 446.
21. Mimran A et al. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. J Hypertens 1988; 6: 919-923.
22. Insua A, Ribstein J, Mimran A. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Postgrad Med J 1988; 64 (Suppl 3): 59-62.
23. Fogari R et al. Effects of amlodipine vs enalapril on microalbuminuria in hypertensive patients with type II diabetes. Clin Drug Invest 1996; 11 (Suppl): 42-49.
24. Melbourne Diabetic Nephropathy Study Group. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. BMJ 1991; 302: 210-216.
25. Velussi M et al. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients. Diabetes 1996; 45: 216-222.
26. Mosconi L et al. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes. Kidney Int 1996; 49 (Suppl 55): S91-S93.
27. Vasmant D, Norbert B. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor. J Cardiovasc Pharmacol 1989; 14 (Suppl 4): S46-S52.
28. Goa KIL, Sorkin EM. Nitrendipine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of hypertension. Drugs 1987; 33: 123-155.
29. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 281: 1039-1057.
30. Trevisan M, Tiengo A. for the North East Microalbuminuria Study Group. Effect of low dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin dependent diabetic patients. Am J Hypertens 1995; 8: 876-883.
31. Mason N. Angiotensin converting enzyme inhibitors and renal function. Ann Pharmacother 1990; 24: 496-497.
32. Yoshida Y et al. Effect of antihypertensive drugs on glomerular morphology. Kidney Int 1989; 36: 626-635.
33. Fogo A, Yoshida Y, Yared A, Ichikawa I. Importance of angiogenic action of ang II in the glomerular growth of maturing kidneys. Kidney Int 1990; 38: 1068-1074.
34. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-394.
35. Morelli E et al. Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990; 39: 76-82.
36. Keane WF, Raij L. Relationship among altered glomerular barrier permselectivity, angiotensin II and mesangial uptake of macromolecules. Lab Invest 1985; 52: 599-604.
37. Bigazzi R et al. Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension. Am J Hypertens 1993; 6: 108-113.
38. Ruilope LM et al. Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int 1994; 45 (Suppl 45): S171-S173.
39. Loutzenhiser R, Epstein M. Effect of calcium antagonists on renal haemodynamics. Am J Physiol 1985; 249: F619-F629.
40. Gansevoort RT et al. The antiproteinuric effect of antihypertensive agents in diabetic nephropathy. Arch Intern Med 1992; 152: 2137-2138.
41. Maki DD, Maj Z, Louis TA, Kakiske BL. Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 1995; 155: 1073-1080.
42. Zucchelli P et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992; 42: 452-458.
43. Lemann J, Jr et al. and the Collaborative Study Group of Angiotensin Converting Enzyme Inhibition in Diabetic Nephropathy. Use of the serum creatinine to estimate glomerular filtration rate in health and early diabetic nephropathy. Am J Kidney Dis 1990; 16: 236-243.
44. Brazy PC, Stead WW, Fitzwilliam JF. Progression of renal insufficiency: role of blood pressure. Kidney Int 1989; 35: 670-674.